World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN (O) : 2455-3301
ISSN (P) : 3051-2557
IMPACT FACTOR: 7.533

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

Abstract

ANTIBIOTIC PROPHYLAXIS IN SURGICAL SITE INFECTION PREVENTION: A PROSPECTIVE OBSERVATIONAL STUDY OF CLEAN AND CLEAN-CONTAMINATED CASES

Bhanavath Abhilash*, Manda Abhishek, Thota Lakshmi, Asfiya Saba, Dr. R. L. Manisha

ABSTRACT

Background: Surgical Site Infections (SSIs) remain a major cause of postoperative morbidity, especially in clean and clean-contaminated surgeries. Optimal antibiotic prophylaxis is essential to prevent SSIs and reduce hospital burden. Objective: To compare the effectiveness of preoperative prophylactic antibiotics versus postoperative therapeutic antibiotics in preventing SSIs and to evaluate the influence of risk factors, timing, and antibiotic choice. Methods: A prospective observational study was conducted for six months in the Department of General Surgery, Malla Reddy Hospital. A total of 250 patients were allocated into two equal groups based on antibiotic strategy. • Group A: Received a single dose of IV pre-operative Antibiotic (ceftriaxone) 30–60 minutes before surgical incision. • Group B: Received only postoperative antibiotic therapy (cefotaxime/ceftriaxone/ fluroquinolones) for 2–3 days without pre-operative prophylaxis. Demographics, comorbidities, surgery type, antibiotic timing, and SSI occurrence were assessed. Statistical tests included Chi-square, ANOVA, and logistic regression. Results: Group A demonstrated a significantly lower SSI rate (23.2%) compared to Group B (48.8%) (p < 0.05). Clean-contaminated surgeries and comorbidities (DM, HTN) were associated with higher SSI risk. Optimal timing (≤30 min) and IV route were strongly protective. Conclusion: Preoperative IV ceftriaxone given within 30 - 60 minutes before surgical incision is markedly more effective than postoperative therapeutic antibiotics in preventing SSIs. Adherence to prophylaxis timing and antibiotic stewardship is essential to improve surgical outcomes.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR